Morgan Stanley Maintains Underweight on Bright Health Gr, Lowers Price Target to $160
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Underweight rating on Bright Health Gr (NYSE:BHG) and lowers the price target from $12,800 to $160.
May 23, 2023 | 11:42 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley maintains an Underweight rating on Bright Health Gr (NYSE:BHG) and lowers the price target from $12,800 to $160.
The lowered price target by Morgan Stanley analyst Ricky Goldwasser indicates a bearish outlook on Bright Health Gr (NYSE:BHG). This could lead to a negative short-term impact on the stock price as investors may adjust their positions based on the new price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100